174 related articles for article (PubMed ID: 389805)
1. In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
Yourassowsky E; Schoutens E; Van der Linden MP; Lismont MJ
Infection; 1979; 7(5):237-9. PubMed ID: 389805
[TBL] [Abstract][Full Text] [Related]
2. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
du T Naudé W; van den Ende J; Botha P; Forder A; Hyland J; de Klerk HC; Neiteler BF; Koornhof HJ; Robinson R; Robins-Browne R; Block C; Appelbaum PC; Africa CW; van Rensburg AJ; Jooste PJ; Crewe-Browne H; Fernandez A
S Afr Med J; 1977 Nov; 52(20):798-800. PubMed ID: 305120
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
Melby K; Midtvedt T; Dahl O
Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergy of cefamandole-tobramycin combinations.
Valenti AJ; Siniscalchi AJ; Andriole VT
Yale J Biol Med; 1977; 50(2):177-82. PubMed ID: 331694
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of cefamandole in vitro.
Meyers BR; Hirschman SZ
J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
Fu KP; Neu HC
J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
10. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
Digranes A; Bjorvatn B
NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
[TBL] [Abstract][Full Text] [Related]
11. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
12. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
Reynolds AV; Hamilton-Miller JM; Brumfitt W
Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.
Klastersky J; Henri A; Vandenborre L
Am J Med Sci; 1973 Jul; 266(1):13-21. PubMed ID: 4198684
[No Abstract] [Full Text] [Related]
14. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
15. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
Forgan-Smith WR; Andrew JH; McSweeney RJ
Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
Laxer RM; Mackay E; Marks MI
Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
[TBL] [Abstract][Full Text] [Related]
19. Emergence of bacteria resistant to gentamicin.
Henri A; Daneau D; Klastersky J
Int J Clin Pharmacol; 1973 Nov; 8(3):216-21. PubMed ID: 4203920
[No Abstract] [Full Text] [Related]
20. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
Rosenthal SL; Freundlich LF; Quraishi MA
Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
